@GarettJones @tiredofthecon @MrWBond @tylercowen @slatestarcodex Again, not going to retrospectively fault Pfizer and BioNTech for making a business decision that was rational *in expectation*.

If the 32-case analysis was adhered to, the vaccine would have probably been approved in late November, yes. But we only know this in retrospect.